Document Detail

Candidate biomarkers for acute rejection of pregnancy after in-utero cell-based therapy in pre-immune embryos via ultrasound-guided celocentesis.
MedLine Citation:
PMID:  22587671     Owner:  NLM     Status:  MEDLINE    
PROBLEM: A maternal serum biomarker profile analysis was performed to determine potential indicators of acute rejection of pregnancy following in-utero cell-based treatments in pre-immune embryos.
METHOD OF STUDY: We used an established non-human primate model for in-utero stem cell therapy at 38-42 days from fertilization. The maternal serum concentrations of nine candidate biomarkers for acute rejection of pregnancy were determined before and after the injection of different cocktails of human umbilical cord blood stem cells into the gestational sac. All animals were then followed until delivery.
RESULTS: Twenty-four hours after celocentesis, two of the animals aborted. These two animals received a cocktail of haemopoietic stem cells with the highest concentration of human CD3(+) cells and showed a twofold increase in maternal serum IL-6 and a threefold increase in prolactin after the procedure. The remaining six animals delivered at term live and normal newborns and only demonstrated an increase in prolactin after the celocentesis procedure.
CONCLUSION: IL-6 and prolactin are master immunoregulators with pleiotropic biological functions that have different maternal serum concentrations depending on pregnancy outcome. These findings suggest that increases in maternal serum prolactin and IL-6 concentration may be associated with acute rejection of pregnancy after in-utero stem cell therapy.
Jacobo L Santolaya; Isabel Galan; Valeria Di Stefano; Sona Jasani; Juan De Leon-Luis; Roman Wolf; Joaquin Santolaya-Forgas
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-05-15
Journal Detail:
Title:  American journal of reproductive immunology (New York, N.Y. : 1989)     Volume:  68     ISSN:  1600-0897     ISO Abbreviation:  Am. J. Reprod. Immunol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-12     Completed Date:  2012-11-13     Revised Date:  2014-05-23    
Medline Journal Info:
Nlm Unique ID:  8912860     Medline TA:  Am J Reprod Immunol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  181-4     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amniocentesis / adverse effects*
Biological Markers / blood
Cord Blood Stem Cell Transplantation / adverse effects*
Disease Models, Animal
Embryo Loss / blood,  diagnosis*,  immunology*
Interleukin-6 / blood
Prolactin / blood
Surgery, Computer-Assisted
Transplantation Chimera
Transplantation, Heterologous
Grant Support
Reg. No./Substance:
0/Biological Markers; 0/Interleukin-6; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of Microflow Conditions to Visible Light Photoredox Catalysis.
Next Document:  Do colonization by dark septate endophytes and elevated temperature affect pathogenicity of oomycete...